WallStSmart

Corteva Inc (CTVA)vsScotts Miracle-Gro Company (SMG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Corteva Inc generates 411% more annual revenue ($17.81B vs $3.48B). CTVA leads profitability with a 5.7% profit margin vs 2.1%. SMG appears more attractively valued with a PEG of 0.81. CTVA earns a higher WallStSmart Score of 52/100 (C-).

CTVA

Buy

52

out of 100

Grade: C-

Growth: 2.0Profit: 6.0Value: 5.0Quality: 6.5
Piotroski: 5/9Altman Z: 1.49

SMG

Hold

48

out of 100

Grade: D+

Growth: 2.7Profit: 5.5Value: 5.3Quality: 6.5
Piotroski: 5/9Altman Z: 1.90
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CTVA.

SMGSignificantly Overvalued (-17.5%)

Margin of Safety

-17.5%

Fair Value

$57.20

Current Price

$52.36

$4.84 premium

UndervaluedFair: $57.20Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CTVA4 strengths · Avg: 9.0/10
Operating MarginProfitability
30.1%10/10

Strong operational efficiency at 30.1%

Market CapQuality
$55.98B9/10

Large-cap with strong market position

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

SMG2 strengths · Avg: 9.0/10
Debt/EquityHealth
-10.1310/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.818/10

Growing faster than its price suggests

Areas to Watch

CTVA4 concerns · Avg: 2.5/10
Return on EquityProfitability
4.0%3/10

ROE of 4.0% — below average capital efficiency

Profit MarginProfitability
5.7%3/10

5.7% margin — thin

P/E RatioValuation
49.9x2/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
-1.2%2/10

Revenue declined 1.2%

SMG4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
1.1%4/10

1.1% revenue growth

Altman Z-ScoreHealth
1.904/10

Grey zone — moderate risk

Profit MarginProfitability
2.1%3/10

2.1% margin — thin

Return on EquityProfitability
-47.6%2/10

ROE of -47.6% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CTVA

The strongest argument for CTVA centers on Operating Margin, Market Cap, Debt/Equity. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bull Case : SMG

The strongest argument for SMG centers on Debt/Equity, PEG Ratio. PEG of 0.81 suggests the stock is reasonably priced for its growth.

Bear Case : CTVA

The primary concerns for CTVA are Return on Equity, Profit Margin, P/E Ratio. A P/E of 49.9x leaves little room for execution misses.

Bear Case : SMG

The primary concerns for SMG are Revenue Growth, Altman Z-Score, Profit Margin. Thin 2.1% margins leave little buffer for downturns.

Key Dynamics to Monitor

SMG carries more volatility with a beta of 1.81 — expect wider price swings.

SMG is growing revenue faster at 1.1% — sustainability is the question.

SMG generates stronger free cash flow (307M), providing more financial flexibility.

Monitor AGRICULTURAL INPUTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CTVA scores higher overall (52/100 vs 48/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Corteva Inc

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Corteva, Inc. (also known as Corteva Agriscience) is a major American agricultural chemical and seed company that was the agricultural unit of DowDuPont prior to being spun off as an independent public company.

Visit Website →

Scotts Miracle-Gro Company

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Scotts Miracle-Gro Company manufactures, markets, and sells lawn and garden products to consumers in the United States and internationally. The company is headquartered in Marysville, Ohio.

Visit Website →

Want to dig deeper into these stocks?